Montelukast%252525252525252525252525252525252525252525252525252520levocetrizine

# Montelukast/Levocetirizine ## Overview Montelukast is a leukotriene receptor antagonist. Levocetirizine is a second-generation antihistamine. This combination is used for the treatment of allergic rhinitis and chronic idiopathic urticaria. ## Primary Indications * Allergic Rhinitis (seasonal and perennial) * Chronic Idiopathic Urticaria ## Adult Dosing The recommended dose for adults and adolescents 12 years of age or older is one tablet (montelukast 10 mg/levocetirizine 5 mg) once daily. ## Pediatric Dosing * **Children 6 to 11 years of age:** One chewable tablet (montelukast 4 mg/levocetirizine 2.5 mg) once daily. * **Children 6 months to 5 years of age:** Dosing depends on the specific formulation (e.g., oral solution) and is typically montelukast 4 mg plus levocetirizine 1.25 mg once daily. Consult product information for exact pediatric formulations and dosing. * Dosing for children younger than 6 months has not been established. ## Dose Adjustments * **Renal Impairment:** * Mild to moderate impairment: No dose adjustment is typically needed for montelukast. Levocetirizine dose needs adjustment. For adults and adolescents with moderate renal impairment (CrCl 30-49 mL/min), the recommended dose is 2.5 mg once daily. * Severe impairment: Consult product information. In general, levocetirizine should be used with caution. * **Hepatic Impairment:** No dose adjustment is typically needed for montelukast. For levocetirizine, caution is advised in patients with hepatic impairment. ## Contraindications * Hypersensitivity to montelukast, levocetirizine, or any component of the formulation. * Severe renal impairment with levocetirizine component. ## Adverse Effects * **Montelukast:** Headache, abdominal pain, nausea, diarrhea, dizziness, fatigue. Neuropsychiatric events (e.g., agitation, depression, suicidal thoughts) have been reported; use with caution in patients with pre-existing psychiatric conditions. * **Levocetirizine:** Somnolence, fatigue, dry mouth, pharyngitis, nasopharyngitis. ## Key Drug Interactions * **CYP1A2 inducers (e.g., rifampin):** May decrease montelukast levels. * **Theophylline:** May increase montelukast levels. * **CNS depressants (e.g., sedatives, tranquilizers, alcohol):** May potentiate the somnolence effect of levocetirizine. ## Monitoring * Assess for efficacy in symptom control of allergic rhinitis or urticaria. * Monitor for neuropsychiatric effects, especially with montelukast. * Monitor renal function if significant renal impairment is suspected. ## Clinical Pearls * Montelukast/levocetirizine is generally well-tolerated. * The neuropsychiatric warnings associated with montelukast are important; patients and caregivers should be educated about potential behavioral changes. * Levocetirizine can cause somnolence; advise patients to use caution when driving or operating machinery. * This combination should not be used for breakthrough symptoms of asthma. *** *This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines for the most up-to-date and comprehensive details before making any treatment decisions.*